Zoltan Szallasi
Zoltan Szallasi
Harvard Medical School
Verified email at childrens.harvard.edu
Title
Cited by
Cited by
Year
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
M Gerlinger, AJ Rowan, S Horswell, J Larkin, D Endesfelder, E Gronroos, ...
N Engl j Med 366, 883-892, 2012
71722012
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
B Györffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi
Breast cancer research and treatment 123 (3), 725-731, 2010
22962010
The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements
Maqc Consortium
Nature biotechnology 24 (9), 1151, 2006
22842006
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
14112017
Robustness of cellular functions
J Stelling, U Sauer, Z Szallasi, FJ Doyle III, J Doyle
Cell 118 (6), 675-685, 2004
11832004
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer
DP Silver, AL Richardson, AC Eklund, ZC Wang, Z Szallasi, Q Li, N Juul, ...
Journal of clinical oncology 28 (7), 1145, 2010
11172010
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
SL Carter, AC Eklund, IS Kohane, LN Harris, Z Szallasi
Nature genetics 38 (9), 1043-1048, 2006
10482006
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
9912017
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
EC de Bruin, N McGranahan, R Mitter, M Salm, DC Wedge, L Yates, ...
Science 346 (6206), 251-256, 2014
9542014
Reliability and reproducibility issues in DNA microarray measurements
S Draghici, P Khatri, AC Eklund, Z Szallasi
TRENDS in Genetics 22 (2), 101-109, 2006
7192006
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients.
B Győrffy, A Lánczky, Z Szállási
Endocrine-related cancer 19 (2), 197-208, 2012
6492012
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
N McGranahan, F Favero, EC de Bruin, NJ Birkbak, Z Szallasi, C Swanton
Science translational medicine 7 (283), 283ra54-283ra54, 2015
5092015
Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer
ML Telli, KM Timms, J Reid, B Hennessy, GB Mills, KC Jensen, Z Szallasi, ...
Clinical cancer research 22 (15), 3764-3773, 2016
4782016
Ca (2+)-dependent and Ca (2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory …
K Ozawa, Z Szallasi, MG Kazanietz, PM Blumberg, H Mischak, ...
Journal of Biological Chemistry 268 (3), 1749-1756, 1993
4541993
Chromosomal instability confers intrinsic multidrug resistance
AJX Lee, D Endesfelder, AJ Rowan, A Walther, NJ Birkbak, PA Futreal, ...
Cancer research 71 (5), 1858-1870, 2011
4222011
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F Favero, T Joshi, AM Marquard, NJ Birkbak, M Krzystanek, Q Li, ...
Annals of Oncology 26 (1), 64-70, 2015
3862015
Neoantigen-directed immune escape in lung cancer evolution
R Rosenthal, EL Cadieux, R Salgado, M Al Bakir, DA Moore, CT Hiley, ...
Nature 567 (7749), 479-485, 2019
3612019
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ...
Nature medicine 16 (2), 214-218, 2010
3492010
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents
NJ Birkbak, ZC Wang, JY Kim, AC Eklund, Q Li, R Tian, C Bowman-Colin, ...
Cancer discovery 2 (4), 366-375, 2012
3402012
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...
Cell 173 (3), 595-610. e11, 2018
3272018
The system can't perform the operation now. Try again later.
Articles 1–20